Purpose: The Screening Instrument for Substance Abuse Potential (SISAP) assesses individuals with a substance abuse history and high risk for opioid dependency or abuse
Target population: Adults
The SISAP indicates good specificity and sensitivity, as well as a high correct classification rate and low rate of misses (Coambs et al. 1996).
This tool can help primary care physicians determine if a patient receiving opioids is at risk for opioid abuse, and has been shown to have relatively high sensitivity and specificity (McPherson and Hersch 2000).
Resistent to deception or falsification (Coambs et al. 1996).
Developed specifically for general practitioners to use within the context of their clinical practice (McPherson & Hersch 2000).
Designed so that patients can fail at several points in the assessment (Coambs et al. 1996).
The tool differentiates between drug and alcohol risk (Butler 2008)
Not validated in pain patients (Butler 2008)
Estimated time: less than 1 minutes to administer and score
Butler SF. Evidence of Co-occuring Alcohol and Prescription Opioid Abuse in Clinical Populations: Implications for Screening. Tufts Health Care Institute, Program on Opioid Risk Management: Conference on Co-Ingestion of Alcohol with Prescription Opioids. 2008.
Coambs RB, Jarry JL, Santhiapillai AC, Abrahamsohn RV, Atance CM. The SISAP: a new screening instrument for identifying potential opioid abusers in the management of chronic nonmalignant pain within the general practice. Pain Res Manag. 1996; 1: 155-162.
McPherson T and Hersch R. Brief substance use screening instruments for primary care settings: a review. Journal of Substance Abuse Treatment. 2000; 18(2): 193-202. Available at: http://www.ncbi.nlm.nih.gov/pubmed/10716103 Accessed on: 2013-09-12.
A member of The Clinical Tools, Inc (CTI) Addiction Training Group: SBIRT Training | Opioid Risk Reduction | Buprenorphine Training
Clinical Tools, Inc. is accredited by the ACCME to provide continuing medical education for physicians. Interactive training is delivered by the FAOS DLearning System and requires IE 7/ higher, Firefox, Chrome or Safari.
Unless otherwise noted, individuals pictured are models and are used for illustrative purposes only.
Initial development of this website was funded by contract #HHSN271200900003C and Grant #1R44DA027245-01 (Medical Student Pain Education) from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health. The website contents are solely the responsibility of the authors and do not necessarily represent the official views of NIDA. Ongoing development and maintenance is funded by the training fee and Clinical Tools, Inc.
This site is for educational purposes only and medical decisions should not be based solely on its content. This site, its authors, and its consultants do not assume liability for errors or omissions.